ABBV-3221   Click here for help

GtoPdb Ligand ID: 10577

Synonyms: ABBV/GLPG-3221 | compound 19 [PMID: 31749908]
Compound class: Synthetic organic
Comment: ABBV-3221(GLPG-3221) is a novel cystic fibrosis transmembrane conductance regulator (CFTR) corrector that is being developed in a collaboration between AbbVie and Galapagos for the treatment of cystic fibrosis [1]. It was designed to provide improved clinical efficacy when used in a triple combination with a CFTR potentiator and a second, but mechanistically distinct, corrector molecule.
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 7
Hydrogen bond donors 1
Rotatable bonds 10
Topological polar surface area 98.19
Molecular weight 578.26
XLogP 3.87
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES COc1ncc(cc1COC1C(N(C(C1C(C)(C)C)C(=O)O)C(=O)C1CCCCO1)c1ccccc1C)C(F)(F)F
Isomeric SMILES COc1ncc(cc1CO[C@@H]1[C@@H](N([C@@H]([C@H]1C(C)(C)C)C(=O)O)C(=O)[C@@H]1CCCCO1)c1ccccc1C)C(F)(F)F
InChI InChI=1S/C30H37F3N2O6/c1-17-10-6-7-11-20(17)23-25(41-16-18-14-19(30(31,32)33)15-34-26(18)39-5)22(29(2,3)4)24(28(37)38)35(23)27(36)21-12-8-9-13-40-21/h6-7,10-11,14-15,21-25H,8-9,12-13,16H2,1-5H3,(H,37,38)/t21-,22+,23-,24-,25-/m0/s1
InChI Key YFEYDNAKCSOOOG-YCXOGWGTSA-N
Bioactivity Comments
In vitro (in cells with the homozygous F508delCFTR mutation from a CF donor), addition of ABBV-3221 (corrector 2; C2) to the combination of ABBV-2222 (corrector 1; C1, with a similar mechanism to lumacaftor) and GLPG1837 (potentiator) increased the CFTR current with an EC50 of 105 nM, and increased the maximum response by almost six-fold, compared to the double ABBV-2222/GLPG1837 combination [1].
Selectivity at ion channels
Key to terms and symbols Click column headers to sort
Target Sp. Type Action Value Parameter Concentration range (M) Reference
CFTR Hs None Binding - - - 1
A CFTR corrector compound that increases protein levels at the cell surface. [1]